Todas as matérias desta categoria, das mais recentes às mais antigas.
Jazz Pharmaceuticals (NASDAQ:JAZZ) agreed to acquire privately held Actio Biosciences for $820 million upfront, adding the clinical-stage epilepsy candidate ABS-1230 to its rare neurological disease portfolio.
On this episode of Stock Movers: - RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from SpaceX last week. - Moderna (MRNA) shares are moving after last week's news that its mRNA flu shot won US approval in an FDA turnaround. - Intel (INTC) shares are moving after the company said it will be offering $15 billion in common stock, taking advantage of renewed interest in its business prospects during the artificial intelligence data center boom.
Outdoor Holding Company (NASDAQ:POWW) reported fiscal Q1 2027 revenue of $14.5 million, up 22.1% year over year, as the company returned to profitability.
Trump administration raids in Charlotte, North Carolina, set off a chain reaction: damaging local businesses and potentially causing long-term economic harm. New data reveals how the deportation campaign may leave social and economic voids in communities across the nation.
Target Hospitality (NASDAQ:TH) reported Q2 2026 revenue of $85.5 million, up 39% year over year, as growth in Workforce Hospitality Solutions and the Dilley, Texas government contract increased results.
Bowman (NASDAQ:BWMN) reported Q2 2026 gross contract revenue of $146.1 million, up 19.7% year over year, while net service billing increased 19.4% to $129 million.
Intel shares fell early on Monday after the company said it will be offering $15 billion in common stock. Intel says the money will be used to pursue growth opportunities in AI. Bloomberg's Ed Ludlow reports.
Village Farms (NASDAQ:VFF) reported Q2 2026 consolidated net sales of $64 million, up 7% year over year, as cannabis revenue reached a record $53.5 million.
Freedom Holding (NASDAQ:FRHC) reported revenue of $732.5 million for the quarter ended June 30, 2026, up 40% year over year, as the financial services company expanded across its business segments.
Mark Zuckerberg's Meta has released a scaled-down AI program consumers can download and use on a personal computer. It's called Muse Glimmer. Ed Ludlow reports.
Axsome Therapeutics (NASDAQ:AXSM) reported Q2 2026 total net product revenue of $218.4 million, up 46% year over year, led by continued growth from AUVELITY.
State Street Investment Management President and CEO Yie-Hsin Hung says gold and private markets are anchoring many portfolios. Hung says the US economy is in good shape and the Federal Reserve should not raise interest rates this year. She speaks on "Bloomberg Surveillance."
